BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108277
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108277
Table 2 Comparison of clinical characteristics between the two groups of patients, n (%)
Clinical characteristics
Non-PNI group (n = 17)
PNI group (n = 65)
t
P value
Tumor location
Head7 (41.18)48 (73.85)-0.033
Body6 (35.29)10 (15.38)
Tail4 (23.53)7 (10.77)
Tumor size (cm), mean ± SD4.06 ± 0.895.37 ± 1.854.158< 0.001
CA19-9 Level, mean ± SD260.67 ± 48.92312.54 ± 57.623.745< 0.001
Overall survival (months), mean ± SD12.76 ± 3.219.85 ± 2.183.5310.002
Abdominal pain3 (17.65)32 (49.23)4.2790.039


Write to the Help Desk